TerminatedNCT01807741
Asenapine for Depression in bipolarity
Medication studyAges 18–55United States
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- CincinnatiSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateSeptember 2013
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 51
- Sponsor
- University of Cincinnati
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT01807741
- Official title
Show the full official title
Asenapine for Bipolar Depression
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cincinnati
Questions about this study
Who is behind this study?
The study sponsor is University of Cincinnati, a university.
Does this study involve medication?
Yes. The study involves medication, including Asenapine and Placebo.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Depression in bipolarity
A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolarity type I.